EN
HI
Summary
As of 30 Aug, 2026, Caplin Point Laboratories stock price is ₹2517.2. During the trading session, the stock has moved between an intraday low of ₹2510.00 and an intraday high of ₹2597.90. Over the last 52 weeks, Caplin Point Laboratories has traded between ₹1500.30 and ₹2699.00.
The stock has recorded a trading volume of 47,400 shares, with a market capitalization of ₹76011696. Its Average Traded Price (ATP) is ₹2545.13, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹2517.20.
Caplin Point Laboratories has an upper circuit limit of ₹3020.60 and a lower circuit limit of ₹2013.80. The total value traded stands at ₹12.06 CR, and the delivery percentage for the day is 47.36%.
The stock is currently traded with a market lot size of 1. Caplin Point Laboratories also offers a dividend yield of 0.16%.
Caplin Point Laboratories share price chart
Caplin Point Laboratories Share Key Metrics
Volume
47400.00
Market Cap
19133.66 CR
LTQ@LTP
1@2517.20
ATP
2545.13
Var Margin
18.27 %
Circuit Range
2013.8-3020.6
Delivery %
47.36 %
Value
12.06 CR
ASM/GSM
No
Market Lot
1
Caplin Point Laboratories Fundamentals
P/E Ratio
28.74
P/B Ratio
5.08
Div. Yield
0.16
Sector P/E
69.42
Sector P/B
3.5
Sec. Div. Yield
0.51
Caplin Point Laboratories Resistance and Support
Pivot 2529.83
Resistance
First Resistance
2558.96
Second Resistance
2577.23
Third Resistance
2606.36
Support
First Support
2511.56
Second Support
2482.43
Third Support
2464.16
Caplin Point Laboratories Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Aug 28 2026 | 2553.3 | 2517.2 | -0.92% | 2597.9 | 2510 |
| Thu Aug 27 2026 | 2529.89 | 2540.69 | 0.97% | 2548.1 | 2500.69 |
| Wed Aug 26 2026 | 2478 | 2516.3 | 1.80% | 2535.5 | 2467.3 |
Caplin Point Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-12 | Quarterly Results & Final Dividend |
| 2026-05-14 | Audited Results & Interim Dividend |
| 2026-02-05 | Quarterly Results |
| 2025-11-06 | Quarterly Results |
| 2025-11-05 | Quarterly Results |
| 2025-08-07 | Quarterly Results |
| 2025-05-15 | Audited Results & Interim Dividend |
| 2025-02-07 | Quarterly Results |
| 2024-11-07 | Quarterly Results |
| 2024-08-07 | Quarterly Results & Final Dividend |
Caplin Point Laboratories News
Caplin Point Laboratories Ltd - 524742 - General Updates
Caplin Point's subsidiary, Caplin Steriles Limited, completed an unannounced US FDA inspection at its injectable and ophthalmic manufacturing facility. The company received 10 procedural Form 483 observations, which are not related to data integrity or repeat findings.
Aug 21 2026 19:07:36
Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Caplin Point Laboratories informed that the audio recording of its Q1 FY27 earnings call, held on August 12, 2026, is now accessible on the company's website. This provides investors with details discussed during the call.
Aug 12 2026 18:46:22
Read More
Caplin Point Laboratories Management
| Name | Position |
|---|---|
| G Venkatram | General Counsel & Company Secretary, Compliance Officer |
| C C Paarthipan | Chairman |
Caplin Point Laboratories Similar Stocks
Neuland Laboratories Ltd.
23205.00
-291.00 (1.24%)
Piramal Pharma Ltd.
218.68
3.73 (1.74%)
Acutaas Chemicals Ltd.
3281.60
-47.60 (1.43%)
Pfizer Ltd.
4703.80
-36.60 (0.77%)
Granules India Ltd.
836.65
4.35 (0.52%)
Astrazeneca Pharma India Ltd.
7106.50
-29.50 (0.41%)
Eris Lifesciences Ltd.
1314.80
2.60 (0.20%)
Cohance Lifesciences Ltd.
449.90
-4.10 (0.90%)
Poly Medicure Ltd.
1733.00
20.40 (1.19%)
Caplin Point Laboratories FAQs
The Buying Price of Caplin Point Laboratories share is 2517.2 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Caplin Point Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Caplin Point Laboratories, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Caplin Point Laboratories shares is 28.74. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Caplin Point Laboratories shares is 5.08. Useful to assess the stock's value relative to its book value.
To assess Caplin Point Laboratories’s valuation compare Sector P/E, P/B which are 69.42 & 3.5 with sector averages, along with growth rates and financial metrics.
The Market Cap of Caplin Point Laboratories is 19133.66 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Caplin Point Laboratories share price is 2699.00 & 1500.30. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Caplin Point Laboratories belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in CAPLIPOINT
Or Download Choice FinX App
Invest in CAPLIPOINT
Account Opening Fee- AMC for 1st Year
- Auto Square Off Charges
- Call & Trade